Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 309 Squamous Cell Carcinoma of Head and Neck 162 Head and Neck Neoplasms 144 Carcinoma, Non-Small-Cell Lung 97 Colonic Neoplasms 89 Rectal Neoplasms 81 Neoplasm Metastasis 70 Neoplasms 59 Pancreatic Neoplasms 40 Carcinoma, Squamous Cell 38 Lung Neoplasms 35 Esophageal Neoplasms 25 Breast Neoplasms 22 Stomach Neoplasms 20 Recurrence 20 Laryngeal Neoplasms 17 Carcinoma 17 Tongue Neoplasms 16 Mouth Neoplasms 16 Esophageal Squamous Cell Carcinoma 14 Oropharyngeal Neoplasms 13 Salivary Gland Neoplasms 12 Adenocarcinoma Of Esophagus 12 Hypopharyngeal Neoplasms 11 Laryngeal Diseases 10 Adenocarcinoma of Lung 10 Uterine Cervical Neoplasms 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Ovarian Neoplasms 9 Nasopharyngeal Carcinoma 9

Interventions

binimetinib 2 Sodium Chloride 2 Aminolevulinic Acid 2 palbociclib 1 methyl 5-aminolevulinate 1 ipatasertib 1 exemestane 1 encorafenib 1 baricitinib 1 atezolizumab 1 Vemurafenib 1 VP-102 1 Trabectedin 1 Spironolactone 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Paclitaxel 1 Low-Level Light Therapy 1 Leuprolide 1 Injections, Intradermal 1 Gonadotropin-Releasing Hormone 1 Fluorouracil 1 Floderm topical cream 1 Everolimus 1 Equipment and Supplies 1 Docetaxel 1 Dacarbazine 1 Cetuximab 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Skin Diseases × Cetuximab × Clear all

NCT00240682 2012-02-22

CTXSCC

Centre Hospitalier of Chartres

Phase 2 Completed

Carcinoma, Squamous Cell, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡